SCHEMBL5134959

SCHEMBL5134959

CCCc1nn(C)c2cnc(N(C)CCc3ccc(OC)c(OC)c3)nc12

nearest known ligand 0.43

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43
KDM4E B2RXH2 3/20 0.42
BLM P54132 1/20 0.42
PMP22 Q01453 1/20 0.42
AOC3 Q16853 1/20 0.41
LMNA P02545 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
ALDH1A1 P00352 3/20 0.39
SMPD1 P17405 5/20 0.39
KMT2A Q03164 2/20 0.38
MEN1 O00255 1/20 0.38
HTT P42858 1/20 0.37
RAB9A P51151 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4900797 0.74 MTOR (0.51) KDM4EALDH1A1KMT2AMEN1
SCHEMBL5134597 0.69 PIK3CB (0.34)
SCHEMBL3122462 0.64 PDE5A (0.36) KDM4ELMNASMN1; SMN2ALDH1A1KMT2A
SCHEMBL427541 0.64 ATM (0.68) CYP1A2CYP3A4CYP2D6KDM4EBLM
SCHEMBL7290182 0.64 CYP1A2 (0.87) CYP1A2CYP3A4CYP2D6KDM4EBLM
SCHEMBL10118317 0.63 CYP1A2 (0.79) CYP1A2CYP3A4CYP2D6KDM4EBLM
SCHEMBL7430428 0.63 CYP1A2 (1.00) CYP1A2CYP3A4CYP2D6KDM4EBLM
Ammonia Solution, Strong SCHEMBL10556485 0.63 ATM (0.66) CYP1A2CYP3A4CYP2D6KDM4EBLM
SCHEMBL10959196 0.62 SIGMAR1 (0.70) CYP1A2CYP3A4CYP2D6BLMPMP22
SCHEMBL6575575 0.62 CYP1A2 (0.83) CYP1A2CYP3A4CYP2D6KDM4EBLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008071650-A2 NOVEL COMPOUNDS USEFUL FOR THE TREATMENT OF DEGENERATIVE & INFLAMMATORY DISEASES GALAPAGOS N.V. (BE) 2008-06-19 WO claimed
WO-2008071650-A2 NOVEL COMPOUNDS USEFUL FOR THE TREATMENT OF DEGENERATIVE & INFLAMMATORY DISEASES GALAPAGOS N.V. (BE) 2008-06-19 WO disclosed